MAPT and epilepsy: Our findings showed abundant p‐tau (Ser202/Thr205)‐related NT and NFT pathology, with variable levels of p‐tau at two phosphorylation sites (Thr205 and Thr181) (Figures 2 and 3), Aβ deposits (Figure 4) and mTOR activation (Figures 5 and 6) in brain biopsies from drug‐resistant epilepsy cases.